RNA degradation analysis reveals ribosome dynamics in complex microbiome samples

Comparative analysis of gut bacteriophage between older and young people

Correlation analysis between gut microbiota characteristics and melasma

Role of folic acid in regulating intestinal flora and short-chain fatty acids based on in vitro fermentation model

Obstructive sleep apnea is related to alterations in intestinal microbiome and impaired intestinal barrier function

Gut microbiota: uterine fibroids patients vs. healthy control

High-throughput sequencing of in vitro fecal fermentation samples

Gut microbiota analysis in poorly controlled diabetes patients with latent TB infection (LTBI) and nonLTBI [16S rRNA]

16S V3-V4 -based microbial profiling of stool, skin and saliva samples of patients affected by systemic sclerosis (SSc)

Interferon inducible pseudouridine modification in human mRNA by quantitative nanopore profiling (Illumina)

Interferon inducible pseudouridine modification in human mRNA by quantitative nanopore profiling

Evaluating the gut microbiota shifts caused by two diets based on ancient grains

An API for dynamic estimation of reference intervals for functional abundances of gut microbiota

Interferon inducible pseudouridine modification in human mRNA by quantitative nanopore profiling (Nanopore)

Lower brown adipose tissue activity is associated with non-alcoholic fatty liver disease but not changes in the gut microbiota

First-in-class microbial ecosystem therapeutics 4 (MET4) in combination with immune checkpoint inhibitors in patients with advanced solid tumours (MET4-IO Trial)

Successful secukinumab therapy in plaque psoriasis is associated with altered gut microbiota and related function change I

Successful secukinumab therapy in plaque psoriasis is associated with altered gut microbiota and related function change II

Successful secukinumab therapy in plaque psoriasis is associated with altered gut microbiota and related function change